CEBPB and neoplasm: These data suggest that C/EBPβ is a critical negative regulator of chemokine production in tumor cells, and the KO of C/EBPβ up-regulates chemokine expression and T cell recruitment and infiltration, thus sensitizing tumor cells for checkpoint blockade therapy.